The effects of two highly selective dopamine D3 receptor antagonists (SB-277011A and NGB-2904) on food self-administration in a rodent model of obesity

Pharmacology Biochemistry and Behavior

Volumn 89, Issue 4, 2008, Pages 499-507

  Thanos, Panayotis K ^a,b,c   Michaelides, Michael ^a,b   Ho, Christopher W ^a   Wang, Gene Jack ^a   Newman, Amy H ^d   Heidbreder, Christian A ^f   Ashby Jr , Charles R ^e   Gardner, Eliot L ^d   Volkow, Nora D ^c  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^e ST JOHN'S UNIVERSITY   (United States)

^f GSK   (Italy)

Author keywords

Anorexia, Anorexigenic; Hunger; Ingestive behavior; Operant conditioning

Indexed keywords

AMIDE; DOPAMINE 3 RECEPTOR BLOCKING AGENT; N [4 [2 (6 CYANO 1,2,3,4 TETRAHYDROISOQUINOLIN 2 YL)ETHYL] CYCLOHEXYL] 4 QUINOLINECARBOXAMIDE; N [4 [4 (2,3 DICHLORPHENYL) 1PIPERAZINYL]BUTYL] 2 FLUORENYLCARBOXAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; DRUG ABUSE; DRUG EFFECT; FOOD INTAKE; INSTRUMENTAL CONDITIONING; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT;

ANIMALS; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; DOPAMINE ANTAGONISTS; EATING; FLUORENES; NITRILES; OBESITY; PIPERAZINES; RATS; RATS, ZUCKER; RECEPTORS, DOPAMINE D3; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; TETRAHYDROISOQUINOLINES;

ANIMALIA; RATTUS; RODENTIA;

EID: 41949090001     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.02.003     Document Type: Article

References (78)

1. Alonso-Galicia M., Brands M.W., Zappe D.H., and Hall J.E. Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity. Hypertension 28 (1996) 1047-1054
2. 3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior. Neuropsychopharmacology 28 (2003) 1272-1280
3. 3 receptor antagonist SB-277011A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats. Synapse (New York NY) 48 (2003) 154-156
4. Barrett A.C., Miller J.R., Dohrmann J.M., and Caine S.B. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats. Neuropharmacology 47 Suppl 1 (2004) 256-273
5. Berridge K.C. Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev 20 (1996) 1-25
6. Booze R.M., and Wallace D.R. Dopamine D2 and D3 receptors in the rat striatum and nucleus accumbens: use of 7-OH-DPAT and [125I]-iodosulpride. Synapse 19 (1995) 1-13
7. Boulange A., Planche E., and de Gasquet P. Onset of genetic obesity in the absence of hyperphagia during the first week of life in the Zucker rat (fa/fa). J Lipid Res 20 (1979) 857-864
8. 2 receptor mRNA. Brain Res 564 (1991) 203-219
9. Brooks-Asplund E.M., Shoukas A.A., Kim S.Y., Burke S.A., and Berkowitz D.E. Estrogen has opposing effects on vascular reactivity in obese, insulin-resistant male Zucker rats. J Appl Physiol 92 (2002) 2035-2044
10. Brunetti L., Michelotto B., Orlando G., and Vacca M. Leptin inhibits norepinephrine and dopamine release from rat hypothalamic neuronal endings. Eur J Pharmacol 372 (1999) 237-240
11. Bull E., Reavill C., Hagan J.J., Overend P., and Jones D.N. Evaluation of the spontaneously hypertensive rat as a model of attention deficit hyperactivity disorder: acquisition and performance of the DRL-60s test. Behav Brain Res 109 (2000) 27-35
12. Cecil J.E., Watt P., Palmer C.N., and Hetherington M. Energy balance and food intake: the role of PPARgamma gene polymorphisms. Physiol Behav 88 (2006) 227-233
13. 3 receptors attenuates cocaine-seeking behaviour in the rat. Int J Neuropsychopharmacol 10 (2007) 167-181
14. Curran E.J., and Watson Jr. S.J. Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: a double in situ hybridization study. J Comp Neurol 361 (1995) 57-76
15. Day J.J., and Carelli R.M. The nucleus accumbens and Pavlovian reward learning. Neuroscientist 13 (2007) 148-159
16. Di Chiara G. From rats to humans and return: testing addiction hypotheses by combined PET imaging and self-reported measures of psychostimulant effects. Commentary on Volkow et al. 'Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies'. Behav Pharmacol 13 (2002) 371-377
17. Di Chiara G., and Bassareo V. Reward system and addiction: what dopamine does and doesn't do. Curr Opin Pharmacol 7 (2007) 69-76
18. Di Ciano P., and Everitt B.J. Differential control over drug-seeking behavior by drug-associated conditioned reinforcers and discriminative stimuli predictive of drug availability. Behav Neurosci 117 (2003) 952-960
19. 3 dopamine receptor antagonist SB-277011-A. Neuropsychopharmacology 28 (2003) 329-338
20. 3 receptor in the rat brain. Neuroscience 65 (1995) 731-745
21. 3 receptors expressed by all mesencephalic dopamine neurons. J Neurosci 20 (2000) 8677-8684
22. 3 receptor is critical in mediating opiate motivation only in opiate-dependent and withdrawn mice. Eur J Neurosci 13 (2001) 995-1001
23. Erlanson-Albertsson C., and Zetterström R. The global obesity epidemic: snacking and obesity may start with free meals during infant feeding. Acta Paediatr 94 (2005) 1523-1531
24. 1 receptors. Eur J Neurosci 18 (2003) 2025-2030
25. Fetissov S.O., Meguid M.M., Sato T., and Zhang L.H. Expression of dopaminergic receptors in the hypothalamus of lean and obese Zucker rats and food intake. Am J Physiol 283 (2002) R905-R910
26. Figlewicz D.P., Evans S.B., Murphy J., Hoen M., and Baskin D.G. Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat. Brain Res 964 (2003) 107-115
27. Figlewicz D.P., Bennett J.L., Naleid A.M., Davis C., and Grimm J.W. Intraventricular insulin and leptin decrease sucrose self-administration in rats. Physiol Behav 89 (2006) 611-616
28. Fukagawa K., Sakata T., Yoshimatsu H., Fujimoto K., Uchimura K., and Asano C. Advance shift of feeding circadian rhythm induced by obesity progression in Zucker rats. Am J Physiol 263 (1992) R1169-R1175
29. Gilbert J.G., Newman A.H., Gardner E.L., Ashby Jr. C.R., Heidbreder C.A., Pak A.C., et al. Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors. Synapse 57 (2005) 17-28
30. Glass M.J., O'Hare E., Cleary J.P., Billington C.J., and Levine A.S. The effect of naloxone on food-motivated behavior in the obese Zucker rat. Psychopharmacology 141 (1999) 378-384
31. Greenwood M.R., Quartermain D., Johnson P.R., Cruce J.A., and Hirsch J. Food motivated behavior in genetically obese and hypothalamic-hyperphagic rats and mice. Physiol Behav 13 (1974) 687-692
32. Hagan M.M., Havel P.J., Seeley R.J., Woods S.C., Ekhator N.N., Baker D.G., et al. Cerebrospinal fluid and plasma leptin measurements: covariability with dopamine and cortisol in fasting humans. J Clin Endocrinol Metab 84 (1999) 3579-3585
33. 2 dopamine receptors in obese Zucker rats: changes during aging. Brain Res 589 (1992) 338-340
34. Hedley A.A., Ogden C.L., Johnson C.L., Carroll M.D., Curtin L.R., and Flegal K.M. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291 (2004) 2847-2850
35. 3 receptors in drug addiction: a review of pharmacological evidence. Brain Res Brain Res Rev 49 (2005) 77-105
36. 3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice. Addict Biol 12 (2007) 35-50
37. Hunt C.E., Lindsey J.R., and Walkley S.U. Animal models of diabetes and obesity, including the PBB/Ld mouse. Fed Proc 35 (1976) 1206-1217
38. Isasi C.R., Soroudi N., and Wylie-Rosett J. Youth WAVE Screener: addressing weight-related behaviors with school-age children. Diabetes Educ 32 (2006) 415-422
39. Ishiwari K., Weber S.M., Mingote S., Correa M., and Salamone J.D. Accumbens dopamine and the regulation of effort in food-seeking behavior: modulation of work output by different ratio or force requirements. Behav Brain Res 151 (2004) 83-91
40. Krugel U., Schraft T., Kittner H., Kiess W., and Illes P. Basal and feeding-evoked dopamine release in the rat nucleus accumbens is depressed by leptin. Eur J Pharmacol 482 (2003) 185-187
41. la Fleur S.E., Vanderschuren L.J., Luijendijk M.C., Kloeze B.M., Tiesjema B., and Adan R.A. A reciprocal interaction between food-motivated behavior and diet-induced obesity. Int J Obes 31 8 (2007) 1286-1294 [Aug]
42. 3 receptor mRNA and binding sites in human brain. Brain Res Mol Brain Res 18 (1993) 187-192
43. Lee B., Platt D.M., Rowlett J.K., Adewale A.S., and Spealman R.D. Attenuation of behavioral effects of cocaine by the metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)-pyridine in squirrel monkeys: comparison with dizocilpine. J Pharmacol Exp Ther 312 (2005) 1232-1240
44. 3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol Rev 49 (1997) 231-252
45. Malcher-Lopes R., Di S., Marcheselli V.S., Weng F.J., Stuart C.T., Bazan N.G., et al. Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. J Neurosci 26 (2006) 6643-6650
46. Martelle J.L., Claytor R., Ross J.T., Reboussin B.A., Newman A.H., and Nader M.A. Effects of two novel D3-selective compounds, NGB 2904 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxa mide] and CJB 090 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benza mide], on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 321 (2007) 573-582
47. McClure S.M., Daw N.D., and Montague P.R. A computational substrate for incentive salience. Trends Neurosci 26 (2003) 423-428
48. McQuade J.A., Benoit S.C., Xu M., Woods S.C., and Seeley R.J. High-fat diet induced adiposity in mice with targeted disruption of the dopamine-3 receptor gene. Behav Brain Res 151 (2004) 313-319
49. Meador-Woodruff J.H., Grandy D.K., Van Tol H.H., Damask S.P., Little K.Y., Civelli O., et al. Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology 10 (1994) 239-248
50. Michaelides M., Wang G., Thanos P., and Volkow N. Age and diet-related changes of striatal dopamine D2 receptor (D2R) binding in obese (Ob) (fa/fa) and lean (Le) Zucker rats revealed by positron emission tomography and autoradiography. Obesity 14 (2006) A130
51. Mistlberger R.E., Lukman H., and Nadeau B.G. Circadian rhythms in the Zucker obese rat: assessment and intervention. Appetite 30 (1998) 255-267
52. Murakami D.M., Horwitz B.A., and Fuller C.A. Circadian rhythms of temperature and activity in obese and lean Zucker rats. Am J Physiol 269 (1995) R1038-R1043
53. NAS, NRC. Guide for the Care and Use of Laboratory Animals (1996), National Academy Press, Washington D.C.
54. 3 receptor antagonists. Bioorganic Med Chem Letters 13 (2003) 2179-2183
55. Ogden C.L., Kuczmarski R.J., Flegal K.M., Mei Z., Guo S., Wei R., et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109 (2002) 45-60
56. 3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions. Int J Neuropsychopharmacol 9 (2006) 585-602
57. Palmiter R.D. Is dopamine a physiologically relevant mediator of feeding behavior?. Trends Neurosci 30 (2007) 375-381
58. Phillips P.E., Walton M.E., and Jhou T.C. Calculating utility: preclinical evidence for cost-benefit analysis by mesolimbic dopamine. Psychopharmacology 191 (2007) 483-495
59. Pijl H. Reduced dopaminergic tone in hypothalamic neural circuits: expression of a "thrifty" genotype underlying the metabolic syndrome?. Eur J Pharmacol 480 (2003) 125-131
60. 3 receptor antagonist, SB-277011-A. J Pharmacol Exp Ther 294 (2000) 1154-1165
61. 3 receptor antagonist SB-277011A on the reinforcing effects of nicotine as measured by a progressive-ratio schedule in rats. Eur J Pharmacol 559 (2007) 173-179
62. Schultz W., Tremblay L., and Hollerman J.R. Reward processing in primate orbitofrontal cortex and basal ganglia. Cereb Cortex 10 (2000) 272-284
63. 3 dopamine receptor in cellular and organismal function. Psychopharmacology 135 (1998) 1-16
64. 3 as a target for neuroleptics. Nature 347 (1990) 146-151
65. 3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res 779 (1998) 58-74
66. Szczypka M.S., Rainey M.A., and Palmiter R.D. Dopamine is required for hyperphagia in Lep(ob/ob) mice. Nat Genet 25 (2000) 102-104
67. Thanos P.K., Katana J.M., Ashby Jr. C.R., Michaelides M., Gardner E.L., Heidbreder C.A., et al. The selective dopamine D3 receptor antagonist SB-277011-A attenuates ethanol consumption in ethanol preferring (P) and non-preferring (NP) rats. Pharmacol Biochem Behav 81 (2005) 190-197
68. Thanos P.K., Michaelides M.M., Piyis Y.K., Wang G.-J., and Volkow N.D. Food restriction markedly increases dopamine D2 receptor (D2R) in striatum in a rat model of obesity. Synapse 62 1 (2008) 50-61
69. Vasselli J.R., Cleary M.P., Jen K.L., and Greenwood M.R. Development of food motivated behavior in free feeding and food restricted Zucker fatty (fa/fa) rats. Physiol Behav 25 (1980) 565-573
70. Volkow N.D., and Wise R.A. How can drug addiction help us understand obesity?. Nat Neurosci 8 (2005) 555-560
71. 3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci 22 (2002) 9595-9603
72. Wang G.-J., Volkow N.D., Logan J., Pappas N.R., Wong C.T., Zhu W., et al. Brain dopamine and obesity. Lancet 357 (2001) 354-357
73. Wang G.-J., Volkow N.D., Thanos P.K., and JS F. Positron emission tomographic evidence of similarity between obesity and drug addiction. Psychiatr Ann 33 (2003) 104-111
74. Wang G.-J., Volkow N.D., Thanos P.K., and Fowler J.S. Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review. J Addict Dis 23 (2004) 39-53
75. Wise R.A. The parsing of food reward. Am J Physiol 291 (2006) R1234-R1235
76. Wise R.A. Role of brain dopamine in food reward and reinforcement. Philos Trans R Soc Lond B Biol Sci 361 (2006) 1149-1158
77. 3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats. Psychopharmacology 176 (2004) 57-65
78. 3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats. Neuropsychopharmacology 31 (2006) 1393-1405